Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $209.95 | Total: $1,049.75 |
| 1 | 10 | $177.84 | Total: $1,778.40 |
| 1 | 25 | $150.67 | Total: $3,766.75 |
| 1 | 50 | $128.44 | Total: $6,422.00 |
| 1 | 100 | $111.15 | Total: $11,115.00 |
Overview
Ronacaleret HCl (SB-751689) is a small molecule CaSR antagonist for the treatment of endocrine and metabolic diseases, skin and musculoskeletal disorders.
Chemical Properties
| Molecular Formula | C25H32ClF2NO4 |
| Molecular Weight | 483.98 |
| CAS Numbers | 702686-96-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C(NC[C@H](COC1=CC(CCC(O)=O)=CC(F)=C1F)O)(C)C)C2CC=3C(C2)=CC=CC3.Cl |
Storage and Handling
0C Short Term, -20C Long Term
References
Fitzpatrick LA, et al. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab. 2011;96[8] 2441-2449.